KNSA
Kiniksa Pharmaceuticals International Plc
NASDAQ · Healthcare · Biotechnology · BM
$77.24
−2.63%Next report
Analyst consensus
- Next report date
- Oct 27, 2026
- EPS estimate
- $0.39
- Revenue estimate
- $259.6M
Latest reported
- Last report date
- Jul 28, 2026
- EPS actual
- $0.30
- EPS estimate
- $0.30
- Revenue actual
- $243.6M
- Revenue estimate
- $226.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -5.4%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $95
- PT range
- $74 – $107
- Analysts
- 6
6 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 28, 2026 | $0.30 | $0.30 | Beat 0.17% | $243.6M |
| Apr 28, 2026 | $0.18 | $0.27 | Beat 50.00% | $214.3M |
| Feb 24, 2026 | $0.29 | $0.17 | Miss -41.38% | $202.1M |
| Oct 28, 2025 | $0.33 | $0.23 | Miss -30.30% | $180.9M |
| Jul 29, 2025 | $0.18 | $0.23 | Beat 27.78% | $156.8M |
| Jul 23, 2024 | -$0.09 | -$0.06 | Beat 33.33% | $108.6M |
| Feb 28, 2024 | -$0.11 | $0.04 | Beat 136.36% | $83.4M |
| Jul 25, 2023 | -$0.16 | -$0.02 | Beat 87.50% | $71.5M |
| May 2, 2023 | -$0.18 | -$0.18 | In line | $48.3M |
| Feb 28, 2023 | -$0.23 | $0.06 | Beat 126.09% | $61.9M |
| Nov 1, 2022 | $0.38 | $0.67 | Beat 76.32% | $99.1M |
| Aug 3, 2022 | -$0.43 | -$0.29 | Beat 32.56% | $27.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026